Focus on Human Papillomavirus (HPV) in the immunocompromised host and in non cervical cancers
|
|
- Reynard Holt
- 5 years ago
- Views:
Transcription
1 Focus on Human Papillomavirus (HPV) in the immunocompromised host and in non cervical cancers Friday 13 February 2009, :30 Holme Building, Science Rd, University of Sydney 9:00 9:15 Welcome Prof. Tania Sorrell (University of Sydney) 9:15 9:30 Overview of Workshop Prof. Raina MacIntyre (University of New South Wales) 9:30 9:55 Epidemiology of HPV in the Australian Context Dr. Julia Brotherton (National Centre for Immunisation Research & Surveillance) (20 mins talk, 5 min questions) 9:55 10:20 Advances in HPV vaccination Prof. Suzanne Garland (Royal Women s Hospital) (20 mins talk, 5 min questions) Symposium/Workshop Human Papillomavirus (HPV) in the immunocompromised host 10:20 10:45 Oncological Perspectives on HPV related non cervical cancers A/Prof Eva Segelov (20 mins talk 5min questions) 10:45 11:00 Morning tea 11:00 11:45 HPV vaccination research in immunocompromised Dr Jane Leong (Merck/CSL) (30 mins talk, 15 min questions) 11:45 12:30 HPV vaccination research in immunocompromised Dr Su peing Ng & Dr Scott Preiss (GSK) (30 min talk s, 15 min question) 12:30 12:55 Neonatal HPV Prof. Robert Booy (National Centre for Immunisation Research & Surveillance) (25 mins talk, 5 min questions)
2 12:55 13:30 Lunch 13:30 15:15 HPV clinical research in Immunosuppressed in Australia Prof. Raina MacIntyre (15 min) Dr. Helen Marshall (15 min) Dr. Jim Buttery (15 min) Dr. Joe Sasadeusz (15 min) Dr. Claire Vajdic (15 min) Dr. Fiona Mackie (15 min) Discussion and research directions (15 min) 15:15 15:35 Modelling of HPV vaccination of boys Dr. David Philp (15 mins talk, 5 min questions) 15:35 15:50 Afternoon tea 15:50 16:30 Discussion panel vaccination of boys and reaching at risk target groups. Supported by: To register please contact Michelle Sams e : m.sams@unsw.edu.au t :
3 Professor Tania Sorrell MBBS (Adelaide), MD (Adelaide), FRACP is Professor of Clinical Infectious Diseases and Director of the Centre for Infectious Diseases and Microbiology, Director of CIDM Biomed, and a member of the executive of CIDM Public Health. She is a graduate of the University of Adelaide, with an MD in Clinical Immunology. She was appointed Professor of Clinical Infectious Diseases at the University of Sydney in Professor Raina MacIntyre is Head of the School of Public Health and Community Medicine at UNSW and professor of infectious diseases epidemiology. She runs a highly strategic research program spanning epidemiology, vaccinology, mathematical modelling, public health and clinical trials in infectious diseases. Her research is supported by NHMRC and ARC grants, and she has received international recognition by way of a major award, the Sir Henry Wellcome Medal and Prize, from the US military in 2007 for her work on bioterrorism. She has also won the Australian Society for Infectious Diseases Award for Advanced Research in Infectious Diseases. She is best known for research in the detailed understanding of the transmission dynamics and prevention of infectious diseases, particularly respiratory pathogens such as influenza, tuberculosis and other vaccine preventable infections. She has a particular interest in adult vaccination with a focus on the elderly and immunosuppressed. Dr Julia Brotherton B Med (Hons), MPH (Hons), Grad Dip App Epi, FAFPHM is a public health physician from Melbourne, Australia. She is a medical graduate from the University of Newcastle, NSW, and has a Masters degree in Public Health from the University of Sydney. She completed her speciality training in Public Health through the NSW Public Health Officers Training Program. For the past 5 years Julia has been involved in research and policy development informing the implementation and evaluation of HPV vaccination programs in Australia. Whilst working as a senior research fellow at the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), Julia served as a member of, and technical writer for, the HPV Working Party of the Australian Technical Advisory Group on Immunisation. Julia has recently commenced working at the Victorian Cytology Service as the epidemiologist for the National HPV Vaccination Program Register and Victorian Cervical Cytology Register. She is currently undertaking a PhD on HPV vaccination in Australia. Professor Suzanne Garland is a clinical microbiologist and sexual health physician, with a particular interest and expertise in infectious diseases as they pertain to reproductive health and the neonate. She also has key research interest in cervical cancer and the role of human papillomaviruses (HPV) being involved in defining the molecular epidemiology of HPV in cervical dysplasia, cervical cancer, and the healthy population within Australia, as well as the chief investigator of a study defining the prevalence of HPV genotypes in urban, rural, indigenous and non indigenous Australian women pre HPV vaccine rollout. She is an Advisor to WHO with a specific role of in roll out of prophylactic HPV vaccines to resource poor countries, as well as, development of international standards for HPV DNA and serological assays. She is the past and inaugural President of the newly formed society, AOGIN (Asian Oceania Research Organization on Genital Infection and Neoplasia), which brings together clinicians and scientists within the Asian and Oceania regions and whose work is related to genital infections and neoplasia Associate Professor Eva Segelov MBBS (Hons 1, PhD, FRACP) is Associate Professor of Medicine at St Vincent s Clinical School, UNSW. She is a medical oncologist specialising in GI cancer with a particular interest in Upper GI cancer and HPV carcinogenesis. With Professor MacIntyre, she has collaborated on projects looking at vaccination in immunosuppressed populations and is interested in long term prevention not only of cervical but other HPV related cancers (anus, head and neck and oesophagus). Dr Jane Leong is the Medical Director at CSL Biotherapies. Following graduation from the University of Melbourne, Jane trained in internal medicine and family medicine before receiving her fellowship from the Royal Australian College of General Practitioners and completing a Masters in Business Administration at the Melbourne Business School. She was in general practice before joining the pharmaceutical industry. She has had over 10 years industry experience including positions of Associate Medical Director and Head of Regulatory Affairs and Medical Information and Pharmacovigilance at GlaxoSmithKline Australia. As Medical Director at CSL Biotherapies, Jane is responsible for various medical functions including global postmarketing pharmacovigilance for vaccines manufactured at the Parkville site and marketed around the world. She has recently been involved in launching GARDASIL for both Australia and New Zealand national HPV vaccination programs.
4 Dr Scott Preiss is the medical scientist for Cervarix working in the medical department at GlaxoSmithKline. Scott has a PhD from the University of Melbourne on HIV Nucleic Acid Vaccines. His scholarly activities have focused on vaccines, virology and the mechanisms pathogens use to avoid the innate and acquired immune systems. He was invited to Latrobe University to present lectures on these topics. Previously he worked at the Victorian Infectious Diseases Reference Laboratory (VIDRL) where he published research on the Hepatitis B virus and Toll Like Receptors. He has also been involved with the Australian/ Thailand HIV Vaccine Consortium which sponsored an HIV vaccine to phase I/II clinical trials. Professor Robert Booy is Head of the Clinical Research team at the National Centre for Immunisation Research and Surveillance (NCIRS) where he joined in March, He is a medical graduate of the University of Queensland (1984) and trained in Paediatrics at the Royal Children's Hospital, Brisbane. Professor Booy has held a range of positions in the UK including Professor of Child Health with the University of London; Lecturer in Paediatric Infectious Diseases at St Mary s Hospital, London; Research Fellow with the University of Oxford; and was the recipient of a Wellcome training fellowship in epidemiology focusing on genetic factors important in meningococcal disease. Professor Booy s research interests extend from understanding the genetic basis of susceptibility to, and severity of, infectious diseases especially influenza and invasive disease caused by encapsulated organisms), the clinical, publichealth, social and economic burden of these diseases (acutely and over the long term) and means by which to prevent or control serious infections through vaccines, drugs and non pharmaceutical measures. Dr Helen Marshall is the Director of the Paediatric Trials Unit, a multidisciplinary research group involved in immunisation research, at the Women s and Children s Hospital and a Senior Lecturer in the Discipline of Paediatrics and Discipline of Public Health at the University of Adelaide. Dr Marshall is a medical graduate who has completed a Master in Public Health degree and the Advanced Vaccinology Course at the Pasteur Merieux Institute in France. Dr Marshall has been an Investigator for over 40 Phase I IV clinical trials in experimental vaccines and immunisation research. Her current research interests include varicella, pertussis, meningococcal and HPV immunisation and translation of vaccine research into public health policy. Dr Jim Buttery is a paediatric infectious diseases physician, actively involved in immunisation policy and research since His major interests are clinical vaccinology, vaccine safety and newborn infections. He is based at Monash Medical Centre and the Royal Children's Hospital as an infectious diseases paediatrician. He is the Director of SAEFVIC, (Surveillance of Adverse Events Following Immunisation), the first integrated vaccine safety service in Australia linking clinical services with adverse event surveillance. He is also the head of the Special Risk Program Leader of the NH&MRC Centre for Clinical Research Excellence in Child and Adolescent Immunisation and is a chief investigator on NHMRC grants of over $3.5 million. He holds a Master s degree in Evidence Based Health Care, and has submitted his MD thesis, relating to rotavirus infections in UK child care nurseries. He serves on the Pharmaceutical Benefits Advisory Committee, is a member of the Paediatric Medicines Advisory Group, and is the Clinical Expert for the National Medicines Policy Committee. Dr. Joe Sasadeusz is an infectious diseases physician primarily based at the Royal Melbourne Hospital with cross appointments at the Alfred Hospital and the Melbourne Sexual Health Centre in Melbourne Australia. He undertook his basic medical training at Monash University Melbourne which was followed by advanced training in general medicine then infectious diseases training in Melbourne. He then moved to the University of British Columbia in Vancouver Canada where he completed a Ph. D in the area of antiviral resistance. His background training is in medical virology and he has worked for several years in the area of infections in patients who have undergone stem cell transplantation Dr Claire Vajdic obtained a PhD in cancer epidemiology from the University of Sydney in That year she was awarded a NHMRC Postdoctoral Training Fellowship, which she undertook at the National Centre in HIV and Clinical Research, University of New South Wales (UNSW). Since 1996 she has examined the risk factors for cancer, including environmental, infectious and immunological determinants. In 2008 she was awarded a NHMRC Career Development Award, and a Cancer Institute NSW Career Development and Support Fellowship. Dr Vajdic is currently Team Leader of the Cancer Aetiology and Prevention Group, at the UNSW Cancer Research Centre.
5 Dr Fiona Mackie is a Senior Staff Specialist in Nephrology at Sydney Children s Hospital. She is the principal investigator on a CARG grant from Roche looking at immunogenicity and duration of immunity with HPV vaccine in children and adults with a kidney transplant ( Co investigators Professor R. McIntyre, Professor Bruce Pussell and Dr Sean Kennedy). Fiona was awarded a PhD from Sydney University in 2001 and trained in clinical nephrology at Stanford University, U.S.A., Royal Prince Alfred and Royal Alexandra Children s Hospitals. Dr David Philp is a Postdoctoral Fellow at the School of Public Health and Community Medicine at UNSW. Since 2005 he has been involved in mathematical modelling of transmissible diseases, especially human papillomavirus and pandemic influenza. His research contributed to the Australian Management Plan for Pandemic Influenza 2006, and CSL's submission to the Pharamaceutical Benefits Advisory Committee for the funding of Gardasil.
Influenza Specialist Group 2015 Program Annual Scientific Meeting 1 & 2 February 2015 Park Royal Hotel Melbourne Airport Melbourne, Australia
Influenza Specialist Group 2015 Program Annual Scientific Meeting 1 & 2 February 2015 Park Royal Hotel Melbourne Airport Melbourne, Australia Day One: Sunday 1 February 2015 Macedon Room 4.30pm 5.00pm
More informationRashes, Fevers and Infectious Diseases Sydney 2015
QRC: 2240 Price One Day : $440 inc. GST Two Days: $660 inc. GST Date 29-30 Jan 2015 Venue Rydges Sydney Central 28 Albion Street, Surry Hills, NW, 2010 CPD Hours 11 Hours 0 Mins Rashes, Fevers and Infectious
More informationInnovations in screening for cervical cancer: The Australian Example
Innovations in screening for cervical cancer: The Australian Example Karen Canfell 1. Director, Cancer Research Division, Cancer Council NSW. 3. Adjunct Professor, School of Public Health, University of
More informationRESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016
RESEARCHER DEVELOPMENT DAYS 2016/2017 Wednesday 30 November 2016 Seminar Room 02/6008, 2 nd Floor UCL Centre for Nephrology Royal Free Hospital Rowland Hill Street London, NW3 2PF DELEGATE PACK Kidney
More informationUICC HPV and CERVICAL CANCER CURRICULUM. UICC HPV and Cervical Cancer Curriculum Chapter 5. Application of HPV vaccines Prof. Suzanne Garland MD
UICC HPV and CERVICAL CANCER CURRICULUM 01 Chapter 5. Application of HPV vaccines Director of Microbiological Research Director of Clinical Microbiology and Infectious Diseases The Royal Women's Hospital
More informationThursday 1 December (The University Club of Western Australia Theatre Auditorium unless otherwise indicated)
Thursday 1 December (The University Club of Western Australia Theatre Auditorium unless otherwise indicated) 07:00am - 07:55am (0:55) 08:00am - 08:45am (0:45) 08:50am - 09:20am (0:30) Chair: A/Prof Peter
More informationConsumer perceptions of Human Papillomavirus (HPV) and HPV Vaccination Program
Consumer perceptions of Human Papillomavirus (HPV) and HPV Vaccination Program PHAA Tuesday 16 th September 2008 Presenting author: Stuart Vawser^ Co-authors: Prof Robert Booy* Katina Exadactylos#, Greg
More informationAustralian Paediatric Surveillance Unit 1993 to 2018
Australian Paediatric Surveillance Unit 1993 to 2018 Celebrating 25 Years of research, advocacy and care for children living with rare conditions The APSU was founded in 1993 in recognition of the gap
More informationGUIDELINES FOR INFECTIOUS DISEASES POLICIES AND PROGRAMS FOR MEDICAL STUDENTS
1 Committee of Deans of Australian Medical Schools GUIDELINES FOR INFECTIOUS DISEASES POLICIES AND PROGRAMS FOR MEDICAL STUDENTS Prepared by Dr Philip Jones, UNSW, and Danielle Brown, CDAMS Overview These
More informationRESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016
RESEARCHER DEVELOPMENT DAYS 2016/2017 Wednesday 30 November 2016 Seminar Room 02/6008, 2 nd Floor UCL Centre for Nephrology Royal Free Hospital Rowland Hill Street London, NW3 2PF DELEGATE PACK Kidney
More informationMelanoma Summit. DRAFT programme. New Zealand November 2018 Cordis Hotel, Auckland. As at 1 September Subject to change.
Melanoma Summit New Zealand 2018 2 3 November 2018 Cordis Hotel, Auckland DRAFT programme As at 1 September 2018 Subject to change. Friday 2 November 2018 TIME TOPIC PRESENTER 0830 Mihi whakatau 0845 Formal
More informationAustralian National Influenza Centres Activity
Australian National Influenza Centres Activity 2011-12 Professor Dominic Dwyer Medical Virologist Director ICPMR and WHO NIC Westmead Hospital Sydney, NSW 2145, Australia dominic.dwyer@sydney.edu.au WHO
More informationImpact for Indigenous Women: The VIP-I study and the National HPV Vaccine Program
Impact for Indigenous Women: The VIP-I study and the National HPV Vaccine Program Dina Saulo 1, Skye McGregor 1, Sepehr Tabrizi 3, Suzanne Garland 3, Julia Brotherton 4,3, Bette Liu 1,2 Rachel Skinner
More informationMelanoma Summit. DRAFT programme. New Zealand November 2018 Cordis Hotel, Auckland. As at 27 June Subject to change.
Melanoma Summit New Zealand 2018 2 3 November 2018 Cordis Hotel, Auckland DRAFT programme As at 27 June 2018 Subject to change. Friday 2 November 2018 TIME TOPIC PRESENTER 0830 Mihi whakatau 0845 Formal
More informationREFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022 Executive Summary Gardasil: Key Metrics in Nine Major
More informationDr Graeme Suthers: The genetic basis of cancer
Dr Graeme Suthers: The genetic basis of cancer Dr Suthers is the head of the Familial Cancer Unit at the Women s and Children s hospital. He will begin the evening with an introduction to cancer and its
More informationOVARIAN CANCER SYMPOSIUM
OVARIAN CANCER SYMPOSIUM Immunotherapy and targeted therapy in ovarian cancer supported by in alliance with 5 MAY 2018 MELBOURNE EVENT PROGRAM 9:30am 10:00am Registration Welcome: Jane Hill (OCA CEO) SESSION
More informationA WORD FROM SIR GUSTAV NOSSAL ABOUT THE NCIRS. Our Vision. Our Purpose To lead and support collaborative research,
1997 217 ABOUT THE NCIRS A WORD FROM SIR GUSTAV NOSSAL Our Vision To be a world leader in translational research optimising the population health benefits of immunisation The National Centre for Immunisation
More informationUpdate on Paediatric Influenza
Update on Paediatric Influenza ISG Annual Scientific Meeting 3 & 4 February 2018 Dr Margie Danchin Paediatrician, Department of General Medicine, RCH Senior Research Fellow, Vaccine and Immunisation Research
More informationPROGRAM AND REGISTRATION BOOKLET
The 1 st University of Sydney and University of Washington Joint Short Course on HIV & STIs 20th 22nd March 2017 LHS picture by Enoch Lau - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=706909
More informationBUILDING TRUST, MANAGING RISK: VACCINE CONFIDENCE AND HUMAN PAPILLOMAVIRUS VACCINATION
BUILDING TRUST, MANAGING RISK: VACCINE CONFIDENCE AND HUMAN PAPILLOMAVIRUS VACCINATION Associate Professor Kristine Macartney Deputy Director, National Centre for Immunisation Research & Surveillance www.ncirs.usyd.edu.au
More informationNational Health & Medical Research Council (NHMRC) Results Fellowships and Australia/European Union Collaborative Grants Scheme 2018
National Health & Medical Research Council (NHMRC) Results Fellowships and Australia/European Union Collaborative Grants Scheme 2018 The NHMRC has publically released results (embargo lifted on 11 October
More informationBDHP Chronic Disease Theme Forum
BDHP Chronic Disease Theme Forum Friday 15 June 2018 Translational Research Institute (TRI), Woolloongabba, Brisbane, Queensland REGISTER TO ATTEND THIS FREE EVENT Metro South Hospital and Health Service
More informationVACCINOLOGY - A PUBLIC HEALTH REVOLUTION
VACCINOLOGY - A PUBLIC HEALTH REVOLUTION M.D. THESIS "If you asked a public health professional to draw up a top-ten list of the achievements of the past century, he or she would be hard pressed not to
More informationigh-sensitivity Cardiac Troponin - A Canadian Viewpoint from CIHR funded studies Friday May 30, 2014
8:50-9:00 Welcome and Introduction Juravinski Cancer Center Lecture Theatre (4 th floor) 699 Concession St. Hamilton, ON L8V 5C2 Introduction to High-Sensitivity Cardiac Troponin Current State 9:00-9:45
More informationHuman papillomavirus and vaccination for cervical cancer
Human papillomavirus and vaccination for cervical cancer Dorothy Machalek Department of Microbiology and Infectious Diseases Royal Women s Hospital, Melbourne, Australia VIRUSES AND CANCER Responsible
More informationDISEASES OF THE THIRD AGE
DISEASES OF THE THIRD AGE Speaker Profiles and Abstracts James Daly Clinical Management of ALL and AML James is the Staff Specialist Haematologist at the Royal Hobart Hospital. He gained his MBBS at the
More informationPRELIMINARY PROGRAM. Sharon Chen David Ellis Debbie Marriott Orla Morrissey Monica Slavin
PRELIMINARY PROGRAM CONVENOR STEERING COMMITTEE David Ellis Debbie Marriott Mycology Masterclass is organised under the auspices of ANZMIG FACULTY Prof Jan-Willem Alffenaar School of Pharmacy, Faculty
More informationThe National Methamphetamine Symposium:
National Centre for Education and Training on Addiction (NCETA) presents: The National Methamphetamine Symposium: Making Research Work In Practice Conference Program 12 May 2015 ANZ Pavilion The Melbourne
More informationProgramme. Co-Chairs. Take the conversation further online follow AIDS #AIDS2016
EVIDENCE TOACTION This session will highlight the essential role that collaborative research plays in improving public sector policies and services for HIV treatment and prevention. Across southern Africa
More informationCVU: What s new? 2 nd December 2013
CVU: What s new? 2 nd December 2013 Dr Margie Danchin Paediatrician, Department of General Medicine, RCH Senior Research Fellow, MCRI Senior Fellow, Department of Paediatrics, The University of Melbourne
More informationUniversity of Sydney Eastern Avenue Auditorium
Sponsorship Proposal The Organising Committee is delighted to invite you to sponsor and/or exhibit at the 2015 Australian Association of Social Workers (AASW) National Symposium University of Sydney Eastern
More informationTHE ALAN COOPER EPIDERM LECTURE
THE ALAN COOPER EPIDERM LECTURE THE FUTURE OF EARLY MELANOMA DETECTION presented by MD, FACD, FAHMS Chair in Dermatology Director, Dermatology Research Centre, The University of Queensland 6:00pm, Friday
More informationChildhood Vaccination and Immunisation
DIRECTORATE GENERAL FOR INTERNAL POLICIES POLICY DEPARTMENT A: ECONOMIC AND SCIENTIFIC POLICY WORKSHOP Childhood Vaccination and Immunisation Brussels, 19 June 2013 MEETING DOCUMENT Policy Department A:
More informationIMMUNISATION: A PUBLIC HEALTH SUCCESS CONTENTS
NSW Public Health Bulletin IMMUNISATION: A PUBLIC HEALTH SUCCESS GUEST EDITORIAL Margaret Burgess National Centre for Immunisation Research The University of Sydney and The Children s Hospital at Westmead
More informationSCCPS Scientific Committee Position Paper on HPV Vaccination
SCCPS Scientific Committee Position Paper on HPV Vaccination Adapted from Joint Statement (March 2011) of the: Obstetrical & Gynaecological Society of Singapore (OGSS) Society for Colposcopy and Cervical
More information14-15 July 2016 is DECLARED. Delirium Clinical And Research Days. Australasian Delirium Association
Australasian Delirium Association 14-15 July 2016 is DECLARED Delirium Clinical And Research Days A two day multidisciplinary symposium for anyone who wants to do better with delirium 3 rd Biennial Conference
More informationDeveloping the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity
Developing the next generation of infection and immunity leaders The Peter Doherty Institute for Infection and Immunity Nobody can decide to discover something, but there are ways of making a discovery
More informationThe HPV Immunisation Programme in NZ. Chris Millar Senior Advisor Immunisation Ministry of Health
The HPV Immunisation Programme in NZ Chris Millar Senior Advisor Immunisation Ministry of Health chris_millar@moh.govt.nz 4 September 2015 Background of NZ s HPV Immunisation Programme Aim: To protect
More informationEvaluation Report. Australian HIV Antiretroviral Guidelines Session. Australasian HIV/AIDS Conference Thursday 18 October 2012 Melbourne
Evaluation Report Australian HIV Antiretroviral Guidelines Session Australasian HIV/AIDS Conference Thursday 18 October 2012 Melbourne 1 Table of Contents Background to the Antiretroviral Guidelines Conference
More informationWednesday 6 March 2019 PAEDIATRIC PAIN SYMPOSIUM DAY Moving from Risk Factors to Resilience in Children and Adolescents with Pain
Wednesday 6 March 2019 PAEDIATRIC PAIN SYMPOSIUM DAY Moving from Risk Factors to Resilience in Children and Adolescents with Pain 0800 Registration Desk Open, Welcome Tea & Coffee Foyer Risk Factors for
More informationWhen Friday 5 Saturday 6 April Where Level 6 Seminar Room Charles Perkins Centre D17 The University of Sydney View map
Obesity Management Workshop for Health Professionals 2019 The Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders The Charles Perkins Centre When Friday 5 Saturday 6 April 2019 0 Where Level
More informationWednesday 6 March 2019 PAEDIATRIC PAIN SYMPOSIUM DAY Moving from Risk Factors to Resilience in Children and Adolescents with Pain
Wednesday 6 March 2019 PAEDIATRIC PAIN SYMPOSIUM DAY Moving from Risk Factors to Resilience in Children and Adolescents with Pain 0800 Registration Desk Open, Welcome Tea & Coffee Foyer Risk Factors for
More informationThe Future of Cervical Screening. Jenny Ross
The Future of Cervical Screening Jenny Ross Introduction Cervical cancer and the Pap smear History of cervical screening in Australia New knowledge about HPV and cervical cancer HPV Vaccination Program
More informationBETTINA ARNDT CURRICULUM VITAE
BETTINA ARNDT CURRICULUM VITAE PERSONAL DETAILS: Date of Birth: 1 August 1949 Penrith, England Marital Status: Divorced, three children EDUCATION: 1969-1971: Bachelor of Science, Australian National University
More informationJAY A. NELSON, PH.D. Executive Director and Vice President
JAY A. NELSON, PH.D. Executive Director and Vice President TRANSLATING RESEARCH INTO HEALTH Jay A. Nelson, Ph.D., is the founder and Executive Director of Vaccine & Gene Therapy Institute of Florida (VGTI-FL)
More informationSEMINAR PROGRAMME Join us on Twitter #brainpower
SEMINAR PROGRAMME Join us on Twitter #brainpower Seminar Programme 09:30 Registration and refreshments 10:00 Introduction and welcome Barbara O Connell Chief Executive Session 1: Current trends in evidence
More informationVaccination Lets work together. Presentation Outline. How vaccines work 22/08/2018. Dr Fiona Ryan IPC Course September 2018.
Vaccination Lets work together Dr Fiona Ryan IPC Course September 2018 Presentation Outline How vaccines work Healthcare worker vaccinations Measles HCWs as promoters of vaccines HPV How vaccines work
More informationThe Renewed National Cervical Screening Program
The Renewed National Cervical Screening Program Implementing the Changes IAN HAMMOND, ALISON LANG & TRACEY BESSELL What are the changes 5 yearly HPV test, partial genotyping Reflex liquid based cytology
More informationREFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - CURRENT AND FUTURE PLAYERS
REFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - Executive Summary Human PapillomaVirus (HPV) Vaccine Sales Expected to Grow Modestly During the Forecast
More informationThursday 7 September 2017: Pre-conference Workshop
Thursday 7 September 2017: Pre-conference Workshop 0900 Registrations open 1000-1010 Welcome 1010-1110 Immunisation coverage in New Zealand Ministry of Health Immunisation update Pharmac Update 1110-1130
More informationREGISTER TO ATTEND THIS FREE EVENT. brisbane diamantina health partners
BDHP Brain and Mental Health Conference Translational research in Neuroscience: Bridging the gap between basic science and clinical practice Tuesday 28 August 2018 Bancroft Auditorium QIMR Berghofer Medical
More informationSPEAKERS MARK ROTH STEPHEN LESLIE LAUREN AYTON
SPEAKERS MARK ROTH SIMON CHEN Ophthalmologist specialising in vitreoretinal surgery, intravitreal anti-vegf therapy and laser cataract surgery. He is a principal investigator for numerous international
More informationThe Human Papillomavirus Vaccine
The Human Papillomavirus Vaccine Publication No. 2011-114-E 9 November 2011 Sonya Norris Social Affairs Division Parliamentary Information and Research Service The Human Papillomavirus Vaccine (Background
More informationYouth Affairs Council Victoria
Youth Affairs Council Victoria presents 12 & 13 February 2019 12 Armstrong Street North, Ballarat Exploring youth health, wellbeing and safety CONFERENCE PROGRAM Youth Affairs Council Victoria s Connecting
More informationVaricella Vaccination in Australia and New Zealand
SUPPLEMENT ARTICLE Varicella Vaccination in Australia and New Zealand Kristine K. Macartney 1 and Margaret A. Burgess 2 1 National Centre for Immunisation Research and Surveillance, The Children s Hospital
More informationLeading in clinical trials. Delivering real-world impact
Leading in clinical trials Delivering real-world impact Leading in clinical trials Real-world impact Leading in clinical trials Real-world impact Leading the way in clinical trials Clinical trials expertise
More informationAustralian Type 1 Diabetes Clinical Research Network Workshop 17 th & 18 th November Summary and Recommendations
Australian Type 1 Diabetes Clinical Research Network Workshop 17 th & 18 th November 2011 Summary and Recommendations Table of Contents 1 Executive Summary... 2 2 Organisation Chart... 3 2.1 Overall model...
More informationWelcome to the National Indigenous Immunisation message stick (NIIMS) January 2014 A vaccine preventable diseases newsletter for health services
Welcome to the National Indigenous Immunisation message stick (NIIMS) January 2014 A vaccine preventable diseases newsletter for health services Wishing you all a wonderful New Year What s new in Indigenous
More informationPresenter Biographies
Presenter Biographies Dr Shyan Vijayasekaran ENT Surgeon Associate Professor Shyan Vijayasekaran MBBS, FRACS grew up in Perth, studied at the University of Western Australia and graduated with distinctions
More informationExcellence in Skin Cancer Diagnosis
Effective management comes down to a strong, trusting relationship between the referring doctor and the reporting histopathologist. Excellence in Skin Cancer Diagnosis Excellence in skin cancer diagnosis
More informationThe HPV Vaccination Programme Early intervention in cancer prevention Northern Ireland
The HPV Vaccination Programme Early intervention in cancer prevention Northern Ireland Immunisations Very cost effective intervention Give vaccine before exposure to disease UK has life course approach
More informationQuick Reference: Immunization Communication Tool For Immunizers HPV 2010
Quick Reference: Immunization Communication Tool For Immunizers HPV 2010 Are young girls being used as guinea pigs for an unproven vaccine? Client knowledge NO. In both clinical trials conducted for the
More informationThe First 5 years of HPV Vaccination in Australia - A National Evaluation
The First 5 years of HPV Vaccination in Australia - A National Evaluation Aditi Dey Stephanie Knox Professor Peter McIntyre Director National Centre for Immunisation Research and Surveillance of Vaccine-Preventable
More informationAtul Humar, MD, MSc Director, Transplant Program, University Health Network, University of Toronto
TIME PROGRAM TITLE 7:30 8:15 Registration and Continental Breakfast 8:15 8:30 Welcoming Remarks TOPIC: VIRUSES Session Chair: Shahid Husain CMV: What is New, What s Hot Atul Humar, MD, MSc Director, Transplant
More informationGlobal HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country ( )
Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) By Region- North America, Europe, APAC and RoW By Country - United
More informationHPV vaccination Effects on cervical screening and the Compass Trial
vaccination Effects on cervical screening and the Compass Trial A/ Prof Marion Saville Executive Director VCS Inc. I am co-pi of the Compass Trial which has received support from Roche Molecular Systems
More informationVaccination Update. Pregnancy. 24-May-17. Disclosures. Overview. Paul Van Buynder Professor, Griffith University Chairman, Immunisation Coalition
Vaccination Update Paul Van Buynder Professor, Griffith University Chairman, Immunisation Coalition Disclosures I have been involved in vaccine studies funded by CSL, Sanofi Pasteur, Merck and Novartis
More informationThe Compass trial: Informing changes to the National Cervical Screening Program
The Compass trial: Informing changes to the National Cervical Screening Program Marion Saville I am Co-Principal Investigator on the Compass trial which has received equipment and funding contribution
More informationUNRAVELING THE MYSTERY BEHIND HIV/AIDS
PRESS RELEASE 3 MAR 2010 UNRAVELING THE MYSTERY BEHIND HIV/AIDS New findings by Nobel Laureate shed light on the elusive AIDS virus and may lead to effective HIV vaccine development 1. Professor Francoise
More informationSPPH Control of Communicable Diseases January - April 2018
SPPH 520 - Control of Communicable Diseases January - April 2018 TIME: LOCATION: INSTRUCTORS: OFFICE: ASSISTANT: Mondays, 9:00AM- 12:00PM Room 143, School of Population and Public Health Bldg Dr. David
More informationPandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report of the Advisory Group
EXECUTIVE BOARD 130th session 20 December 2011 Provisional agenda item 6.9 Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits: report of the Advisory
More informationwww.brisbaneeyeclinic.com.au Brisbane Eye Clinic is a modern ophthalmology practice focused on the provision of excellent medical eye care. The Clinic has two convenient consulting locations, our Wickham
More informationHPV year 1 in Quebec Different perspectives, different outcomes. Monique Landry MD Ministry of Health of Quebec June 2009
HPV year 1 in Quebec Different perspectives, different outcomes Monique Landry MD Ministry of Health of Quebec June 2009 Outline The program The preparation The results The hypothesis The evaluation THE
More informationAustralian Type 1 Diabetes. Research Resource Map
Australian Type 1 Diabetes Research Resource Map 1 Introduction The Resource Mapping Project has been supported by the Macquarie Group Foundation through its pioneering, long term partnership with the
More informationBiographies. Understanding Modern Vaccines: Perspectives in Vaccinology
Volume 1/Issue 1/xiiiexx Contents lists available at ScienceDirect Understanding Modern Vaccines: Perspectives in Vaccinology Biographies Paolo Bonanni, MD: Paolo Bonanni is Full Professor of Hygiene in
More informationAMBITION NEWS The Ambition-cm Trial Newsletter (Issue 5: September 2017)
In this issue: Ethical and regulatory updates Training Courses PhD Opportunity and MSc Scholarship Welcome to our colleagues from Blantyre and Lilongwe Team email address: ambtition@lshtm.ac.uk Nabila
More informationReal-life challenges in implementing public strategies for HPV vaccination in developing countries, and strategies to increase immunization coverage
Real-life challenges in implementing public strategies for HPV vaccination in developing countries, and strategies to increase immunization coverage Prof. Charbell Miguel Haddad Kury, MD Pediatrician Infectious
More informationNational Indigenous Women s Health Workshop
National Indigenous Women s Health Workshop An open, interactive, engagement forum to move towards a National Partnership as a united voice in Indigenous Women's Health. Funded by the Australian Government
More informationAustralian Technical Advisory Group on Immunisation Then and Now. Professor Terry Nolan AO
Australian Technical Advisory Group on Immunisation Then and Now Professor Terry Nolan AO Declarations See World Health Organisation SAGE website http://www.who.int/immunization/sage/meetings/2017/october/sa
More informationIsrael Makov President and Chief Executive Officer Teva
Israel Makov President and Chief Executive Officer Israel Makov has been the President and Chief Executive Officer of since April 2002. Previously he served as 's Chief Operating Officer from January 1,
More informationCNRC. Children s Nutrition Research Centre Brisbane, Australia. World class research into children s nutrition
CNRC Children s Nutrition Research Centre Brisbane, Australia World class research into children s nutrition Mission To improve the health of children and young people through scientific research and education
More informationHealth benefits versus intussusception risk of rotavirus vaccination in Australia
Health benefits versus intussusception risk of rotavirus vaccination in Australia Julie Bines 1 On behalf of co-authors: John Carlin 1, Kristine Macartney 2, Katherine Lee 1, Helen Quinn 2, Jim Buttery
More informationChurchill walk. 18 th August, 2016 The Children s Hospital at Westmead
Churchill walk 18 th August, 2016 The Children s Hospital at Westmead Program 11.30 - Welcome - CHW main entrance - Level 2 11.30-12.30 Walking the labyrinth Hospital tour with special detours to the gait
More informationDigestive & Metabolic Diseases
4 th World Congress on Digestive & Metabolic Diseases October 29-30, 2018 San Francisco, California, USA Invitation Dear Attendees, We are glad to announce the 4 th World Congress on Digestive & Metabolic
More informationTime Topic / Activity Presenter(s)
Social Innovation Fund Pre-Launch Training Agenda September 14, 2013 Time Topic / Activity Presenter(s) 8:00 REGISTRATION 8:30 Welcome - JAHF and AIMS Center Introductions 8:50 Agenda & Materials Review
More informationPHN - Western Victoria Immunisation Forum Chelsea Taylor Senior Policy Advisor Immunisation, DHHS 21 October 2017
PHN - Western Victoria Immunisation Forum 2017 Chelsea Taylor Senior Policy Advisor Immunisation, DHHS 21 October 2017 Australian Immunisation Register (AIR) quarterly immunisation coverage data Victoria,
More information2nd World Congress on Infectious and rare disease. September 09-10, 2019 Bangkok, Thailand
2nd World Congress on Infectious and rare disease September 09-10, 2019 Bangkok, Thailand Invitation We cordially invite you all the participants from all over the world to attend 2nd World Congress on
More informationHepatitis B and C in Australia. Annual Surveillance Report Supplement 2016
Hepatitis B and C in Australia Annual Surveillance Report Supplement 216 The Kirby Institute for infection and immunity in society 216 ISSN 226-163 (Online) This publication is available at Internet address
More informationTowards the elimination of HPV
Towards the elimination of HPV Richard Hillman June 11th 2018 Potential conflicts of interest Potential Conflicts of Interest Declaration CSL research + travel + support for student MSD International Scientific
More informationInfluenza Updates. The newsletter of the WHO Collaborating Centre for Reference and Research on Influenza in Melbourne
Influenza Updates The newsletter of the WHO Collaborating Centre for Reference and Research on Influenza in Melbourne Thank you and happy holidays Volume 5, Issue 3, December 216 As 216 draws to a close
More informationHPV Immunisation Statistics Scotland
HPV Immunisation Statistics Scotland School Year 2017/18 27 November 2018 A National Statistics publication for Scotland This is a National Statistics Publication National Statistics status means that
More informationDIVISION OF NEPHROLOGY
The Division s funding from the NIH has increased from $3.7 Million in 2001 to over $11 Million in 2006. DIVISION OF NEPHROLOGY DR. BARBARA MURPHY was voted President-Elect of the American Society of Transplantation
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal Review of TA215; Pazopanib for the first line treatment of advanced
More informationOPPORTUNISTIC HPV VACCINATION: AN EXPANDED VISION
OPPORTUNISTIC HPV VACCINATION: AN EXPANDED VISION SUMMARY POSITION Human papillomavirus (HPV) infection is preventable but not adequately prevented. At present, Canada has a robust school vaccination program
More informationCONFERENCE PROGRAM. February 26 th 27 th, 2010 Eastern Avenue Auditorium University of Sydney
CONFERENCE PROGRAM February 26 th 27 th, 2010 Eastern Avenue Auditorium University of Sydney Welcome Message Welcome to Sydney and the Towards a Brighter Future Conference. The vision for the conference
More informationThe Centre for Neuroscience, Recovery & Mental Health KEY STRATEGIC PRIORITIES
The Centre for Neuroscience, Recovery & Mental Health KEY STRATEGIC PRIORITIES 2014-2018 Diamantina Health Partners Diamantina Health Partners (DHP) was launched in July 2011, bringing together eight Queensland
More informationCanadian Conference on Physician Leadership
2018 Canadian Conference on Physician Leadership Sponsorship Package Corporate Sponsors istock April 20-21, 2018 JW Marriott Parq Hotel Vancouver, British Columbia Canada Corporate Sponsorship Canadian
More informationInfluenza Surveillance to Inform Decision Making
Influenza Surveillance to Inform Decision Making Ms Kate Pennington Epidemiologist Assistant Director, Vaccine Preventable Diseases Surveillance Office of Health Protection Department of Health and Ageing
More informationGuidelines for immunisation of children following treatment with high dose chemotherapy and Haematopoietic Stem Cell Transplantation (HSCT)
Guidelines for immunisation of children following treatment with high dose chemotherapy and Haematopoietic Stem Cell Transplantation (HSCT) Version 2.0 Approved by Haem / Onc Senior Clinical Management
More information